← Leaderboards
Young Hwan Chang
Oregon Health & Science University
$1,522,018
Attributed
$3,044,035
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $629.3K · FY2021–25$1M$750K$500K$250K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,044,035 · 1
By mechanism
R01$3,044,035 · 1
Top collaborators
- Melissa H Wong5 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Summer Lynne Gibbs$14,875,792
- Tianyi Mao$8,621,676
- Haining Zhong$12,266,903
- Kathleen A Grant$37,723,630
- Marilyn Huckans$1,872,958
Others in their field
Other Emerging Leaders on “American Cancer Society”
- Leonard Freedman · Leidos Biomedical Research, Inc.$41,527,040
- Lynn Briscoe · Leidos Biomedical Research, Inc.$23,339,595
- Bronwen Shaw · Medical College Of Wisconsin$10,328,749
- Daniel Sing-Kwong Tsze · Columbia University Health Sciences$6,822,930
- Stephen Blumberg · National Institute On Deafness And Other Communication Disorders$4,725,000
- Leonard Freedmand · Leidos Biomedical Research, Inc.$4,484,700
Research focus
American Cancer SocietyAdvanced DevelopmentBiologicalBiological MarkersBiological ProcessBiomarker DevelopmentBiomarker PanelBiomarker ValidationCancer CellCancer EtiologyCancer ImagingCell FusionCell PhysiologyCellsCellular ImagingCessation Of LifeCharacteristicsChemotaxisCohortColon Cancer PatientsColorectal CancerComputational BiologyDeep LearningDetection
Grant awards (5)
Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease$605,993
R01 · FY2025 · CA
Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease$585,409
R01 · FY2024 · CA
Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease$606,669
R01 · FY2023 · CA
Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease$616,688
R01 · FY2022 · CA
Integrative single cell analyses of inflammation-derived circulating hybrid cells to identify aggressive disease$629,276
R01 · FY2021 · CA